Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Elliot Stieglitz"'
Autor:
Claire Johns, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott, Regina Dagher, Helen Nadel, Jay Balagtas, Catherine Aftandilian, Sneha Ramakrishna, Norman Lacayo, Kara L. Davis, Elliot Stieglitz, Liora Schultz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Standard testing for disease evaluation in B-cell acute lymphoblastic leukemia (B-ALL) includes examination of the bone marrow and cerebrospinal fluid. Radiographic or functional imaging are indicated when clinical signs of non-CNS extramedullary dis
Externí odkaz:
https://doaj.org/article/804f63d9ff31435e95f8f42657723ec2
Autor:
Astrid Wintering, Anna Hecht, Julia Meyer, Eric B. Wong, Juwita Hübner, Sydney Abelson, Kira Feldman, Vanessa E. Kennedy, Cheryl A.C. Peretz, Deborah L. French, Jean Ann Maguire, Chintan Jobaliya, Marta Rojas Vasquez, Sunil Desai, Robin Dulman, Eneida Nemecek, Hilary Haines, Mahmoud Hammad, Alaa El Haddad, Scott C. Kogan, Zied Abdullaev, Farid F. Chehab, Sarah K. Tasian, Catherine C. Smith, Mignon L. Loh, Elliot Stieglitz
Publikováno v:
Haematologica, Vol 999, Iss 1 (2023)
Mutations in five canonical Ras pathway genes (NF1, NRAS, KRAS, PTPN11 and CBL) are detected in nearly 90% of patients with juvenile myelomonocytic leukemia (JMML), a frequently fatal malignant neoplasm of early childhood. In this report, we describe
Externí odkaz:
https://doaj.org/article/6b7a3df1a4054f309e85875af70a1441
Autor:
Savannah S. Shumock, William C. Temple, Amanda Marinoff, Kathryn Aaronson, Erica Southworth, Simayijiang Xirenayi, Alex G. Lee, Stanley G. Leung, E. Alejandro Sweet‐Cordero, Michelle Hermiston, Christine Higham, Elliot Stieglitz
Publikováno v:
Cancer Reports, Vol 6, Iss 12, Pp n/a-n/a (2023)
Abstract Background The development of tyrosine kinase inhibitors (TKIs) has significantly improved survival rates among patients with Philadelphia chromosome (Ph+) B cell acute lymphoblastic leukemia (B‐ALL). Ph‐like B‐ALL patients lack the BC
Externí odkaz:
https://doaj.org/article/b939915b6792494fb624d0253983d87f
Autor:
Elliot Stieglitz, Aaron C Logan, Emilio Ramos, William C Temple, Matthew A Nix, Akul Naik, Adila Izgutdina, Benjamin J Huang, Gianina Wicaksono, Paul Phojanakong, Juan Antonio Camara Serrano, Elizabeth P Young, Fernando Salangsang, Veronica Steri, Simayijiang Xirenayi, Michelle Hermiston, Arun P Wiita
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Approximately 50% of patients who receive anti-CD19 CAR-T cells relapse, and new immunotherapeutic targets are urgently needed. We recently described CD72 as a promising target in B-cell malignancies and developed nanobody-based CAR-T cell
Externí odkaz:
https://doaj.org/article/2d39e3cf7d6f4d60aeb1265961906c97
Autor:
Jeffrey Rubnitz, Ghayas C. Issa, Eytan M. Stein, Neerav Shukla, Wendy Stock, Andrius Žučenka, Sajad Khazal, Nandita Khera, Elliot Stieglitz, Jeremy Rubinstein, Galit Rosen, Rachel Ghiraldi, Huy Van Nguyen, Nicole Mcneer, C. Michel Zwaan
Publikováno v:
HemaSphere, Vol 7, p e221187f (2023)
Externí odkaz:
https://doaj.org/article/c2daa4c9e27a49ec8d84cb363b109f0b
Publikováno v:
HemaSphere, Vol 7, p e991262c (2023)
Externí odkaz:
https://doaj.org/article/3c7a4d92d926426fb64f93fce222c3b6
Autor:
Juwita Huebner, Sherin Xirenayi, Jose Rivera, Bonell Patiño Escobar, Alex G Lee, Kamal Mandal, Ernesto Diaz-Flores, Arun Wiita, Elliot Stieglitz
Publikováno v:
HemaSphere, Vol 7, p e40333db (2023)
Externí odkaz:
https://doaj.org/article/73db51895c944c3aa972b90272aec86a
Autor:
Takahiro Imaizumi, Julia Meyer, Manabu Wakamatsu, Hironobu Kitazawa, Norihiro Murakami, Yusuke Okuno, Taro Yoshida, Daichi Sajiki, Asahito Hama, Seiji Kojima, Yoshiyuki Takahashi, Mignon Loh, Elliot Stieglitz, Hideki Muramatsu
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Juvenile myelomonocytic leukemia (JMML) is a rare heterogeneous hematological malignancy of early childhood characterized by causative RAS pathway mutations. Classifying patients with JMML using global DNA methylation profiles is useful for
Externí odkaz:
https://doaj.org/article/84c8fbf52cc34fe08afed256cf5acc20
Autor:
Anupam Verma, Yueh-Yun Chi, Jemily Malvar, Adam Lamble, Sonali Chaudhury, Archana Agarwal, Hong-Tao Li, Gangning Liang, Roy Leong, Patrick A. Brown, Joel Kaplan, Eric S. Schafer, Tamra Slone, Melinda Pauly, Bill H. Chang, Elliot Stieglitz, Alan S. Wayne, Nobuko Hijiya, Deepa Bhojwani
Publikováno v:
Cancers, Vol 16, Iss 3, p 496 (2024)
Improvements in survival have been made over the past two decades for childhood acute myeloid leukemia (AML), but the approximately 40% of patients who relapse continue to have poor outcomes. A combination of checkpoint-inhibitor nivolumab and azacit
Externí odkaz:
https://doaj.org/article/498c6ca081b64cb09353822d5f07e337
Autor:
Alyssa L. Kennedy, Kasiani C. Myers, James Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani, Gwen M. Muscato, Robert H. Klein, Kaitlyn Ballotti, Shanshan Liu, Chad E. Harris, Ashley Galvin, Maggie Malsch, David Dale, John M. Gansner, Taizo A. Nakano, Alison Bertuch, Adrianna Vlachos, Jeffrey M. Lipton, Paul Castillo, James Connelly, Jane Churpek, John R. Edwards, Nobuko Hijiya, Richard H. Ho, Inga Hofmann, James N. Huang, Siobán Keel, Adam Lamble, Bonnie W. Lau, Maxim Norkin, Elliot Stieglitz, Wendy Stock, Kelly Walkovich, Steffen Boettcher, Christian Brendel, Mark D. Fleming, Stella M. Davies, Edie A. Weller, Christopher Bahl, Scott L. Carter, Akiko Shimamura, R. Coleman Lindsley
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Understanding the molecular basis of leukaemia predisposition is essential for intervention. The authors here investigate germline genetic leukaemia predisposition by studying Shwachman-Diamond syndrome and report compensatory inactivating mutations
Externí odkaz:
https://doaj.org/article/911d91b30d4548af8f9e72d025592f4b